CD8A and cancer: The CD4/CD8 ratio is inverted early after HIV infection, and its persistence after ART has been associated with increased cancer incidence and all-cause mortality, emphasizing this specific feature of HIV-associated immunologic perturbation as impactful in antitumor responses.